Company: TXG
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050332
Chunk: 84

Company: 10x Genomics, Inc.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part II, Item 2
Chunk 84
---
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

We completed the acquisition of Scale Biosciences, Inc. on August 11, 2025, in which a portion of the consideration for the acquisition consisted of the unregistered issuance of 1,099,992 shares of our Class A common stock, valued at $13.5 million. The sales of these securities were deemed to be exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon Section 4(a)(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder) as transactions by an issuer not involving any public offering. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions.

For additional information about this acquisition, see Note 3, Asset Acquisition, to the unaudited consolidated financial statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q.

Item 5.    Other Information.

None of our directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended September 30, 2025, as such terms are defined under Item 408(a) of Regulation S-K.

27

Table of Contents

Item 6.    Exhibits.

ExhibitNumberIncorporated by ReferenceExhibit TitleFormFile No.ExhibitFiling DateFiled Herewith3.1Amended and Restated Certificate of Incorporation of the Registrant.8-K001-390353.19/16/20193.2Amended and Restated Bylaws of the Registrant.10-Q001-390353.211/3/20224.1Form of Stock Certificate for Class A common stock of the Registrant.S-1333-2333614.28/19/201931.1Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X31.2Certification of Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X32.1*Certification of Principal Executive Officer Pursuant to Section 906 of the Sar